Get Real Time Here
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
| Open357.400 | Close353.030 |
| Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
| Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 2.550 | 3.000 | 0.4500 | ||||
| REV | 687.880M | 681.100M | -6.780M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
| 2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
| 2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
| 2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
| MEDP | Medpace Hldgs | 0.78% | 7.4B |
| A | Agilent Technologies | 1.53% | 32.6B |
| TXG | 10x Genomics | -1.34% | 4.9B |
| SYNH | Syneos Health | -0.07% | 4.4B |
How do I buy Bio-Rad Laboratories (BIO) stock?
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Who are Bio-Rad Laboratories's (BIO) competitors?
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories (BIO) stock?
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Rad Laboratories (BIO)?
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
Does Bio-Rad Laboratories (BIO) pay a dividend?
There is no dividend information for Bio-Rad Laboratories.
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
Is Bio-Rad Laboratories (BIO) going to split?
There is no upcoming split for Bio-Rad Laboratories.
What sector and industry does Bio-Rad Laboratories (BIO) operate in?
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.